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Digest: City of Hope National Medical Center v. Genentech, Inc. 
Mike M. Khalilpour 
Opinion by Kennard, J., expressing the unanimous view of the Court. 
Issues 
(1) Does a fiduciary relationship necessarily arise when a party, in 
return for royalties, entrusts a secret scientific discovery to another party to 
develop, patent, and to commercially exploit? 
(2) Did the evidence that the plaintiff introduced at trial to prove that 
the defendant had breached a fiduciary duty so prejudice the jury as to 
require setting aside the jury's award of compensatory damages for breach 
of contract? 
Facts 
In the mid-1970's, two scientists employed by City of Hope developed 
a groundbreaking scientific process enabling production of medicines 
having great "therapeutic and commercial value."' The two scientists, 
along with a venture capitalist, applied for a confidential grant application 
relating to this discovery, and proceeded to incorporate the company, 
Genentech, Inc. (Genentech), to exploit this biotechnology.2 
During this time, Genentech contacted City of Hope and started 
negotiations to enter into a contract. 3 The contract stated that Genentech 
would manufacture and sale the new discovery in laboratories provided by 
City of Hope, and Genentech would then secure patents that emerged from 
this work.4 City of Hope would then publish the results of this work and 
earn royalty income, for a specified period of time, from the sales of the 
new scientific discovery, provided that the publication was done by City of 
Hope under this agreement.5 The contract also provided that Genentech 
would exclusively own the patents and other "proprietary" property. 6 
Royalties paid to City of Hope would also include income derived by 
Genentech via licensing agreements with third parties and lawsuit 
1 City of Hope Nat'! Med. Ctr. v. Genentech, Inc., 181 P.3d 142, 146-47 (Cal. 2008). 
2 !d. at 147. 
3 !d. 
4 !d. 
5 !d. 
6 !d. 
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settlements and awards for potential infringers, should they arise. 7 The 
contract also expressly provided that the agreement did not create an 
agency or joint venture relationship and that City of Hope would act as an 
independent contractor. 8 
By the late 1980's and early 1990's, Genentech had secured many 
patents in which City of Hope's two scientists were listed as inventors and 
had granted numerous licenses for its patents with third parties. 9 
Genentech divulged some of the companies it had granted licenses to, but 
not all, despite exchanges between the two parties whereby City of Hope 
requested documents pertaining to licenses granted and royalties 
reporting. 10 
During this time, City of Hope received over $300 million in royalties 
from sales due to Genentech's licensing of certain products, but City of 
Hope had not received any royalties from certain other products. 11 
Also in the 1990's, Genentech sued a party alleging infringements of 
certain patents whereby the parties ended settling for $145 million plus 6% 
royalties on future sales resulting form the infringements. 12 Initially, City 
of Hope did not receive any royalties from this settlement. 13 Eventually, 
Genentech agreed to pay City of Hope $3 million and 1.75% of royalties 
(of the 6% per settlement). 14 In 1998, Genentech settled another 
infringement lawsuit for $20 million, of which City of Hope did not receive 
any payment. 15 
City of Hope brought this instant action, alleging claims for breach of 
fiduciary duty, breach of contract, and breach of the implied covenant of 
good faith and fair dealing. 16 
Analysis 
1. Fiduciary Relationship 
The Court first addressed the issue of whether the contract itself 
created a fiduciary relationship. 17 The Court began with the principle that a 
fiduciary relationship exists when a party "must either knowingly 
undertake to act on behalf and for the benefit of another, or must enter into 
a relationship which imposes that undertaking as a matter of law." 18 The 
7 !d. at 148. 
8 !d. 
9 /d. at 148-49. 
10 !d. 
II fd. at 149. 
12 !d. 
13 !d. 
14 !d. 
15 !d. 
16 !d. 
17 !d. at 150-54. 
18 !d. at 150 (internal quotations omitted). 
r 
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Court found no express language of the contract to indicate that Genentech 
was acting primarily for the benefit of City of Hope. 19 The contract 
provisions, the Court found, indicated the parties had a common goal to 
achieve a "mutually beneficial arrangement," the express terms of which 
did not expressly provide for Genentech to subordinate its interests to those 
of City of Hope.20 Nor did the contract indicate that Genentech undertook 
obligations of a fiduciary. 21 
The Court next examined whether "an agreement to develop, patent, 
and commercially exploit a secret scientific discovery in exchange for 
payment of royalties" is a type of relationship that imposes fiduciary 
obligations.22 Looking to the contract, the Court found that the express 
terms stated that the agreement did not create an agency, venture, or 
partnership relationship between the parties.23 
The Court, relying on Wolf v. Superior Courf4, concluded that a 
fiduciary duty does not arise simply from a party's 
contractual right to receive compensation contingent upon the receipt of future 
revenues ... or from the profit-sharing provisions of an agreement, or from [the 
party's] contractual right to an accounting, but that the profit-sharing provisions 
of the contract did shift burden of proof to defendant to prove compliance with 
contractual payment obligations.25 
In accordance with Wolf, the court reasoned that fiduciary obligations 
are not created when one party entrusts valuable intellectual property to 
another for commercial development in exchange for the payment of 
compensation contingent on the venture's commercial success.26 
Genentech contended that, during closing arguments, City of Hope's 
counsel made improper references to "concealment of evidence" and that 
such evidence was inadmissible to show Genentech breached the 
agreement.27 The Court concluded that when a "party's conduct occurring 
between execution of the contract and a dispute about the meaning of the 
contract's terms may reveal what the parties understood and intended those 
terms to mean."28 Therefore, evidence of conduct, including concealment 
of certain information, which Genentech was charged with concerning 
certain third party licensing agreements and reporting royalties, was 
admissible to resolve ambiguities in the contract's language.29 
19 !d. 
20 !d. 
21 !d. 
22 !d. 
23 !d. 
24 130 Cal. Rptr. 2d 860 (App. Ct. 2003). 
25 City of Hope, 181 P.3d at 153. 
26 fd. at 154. 
27 !d. at 155. 
2' fd. 
29 fd. 
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2. Prejudice to Jury 
Genentech contended that, during closing arguments, City of Hope's 
counsel improperly referenced the importance of determining witness 
credibility in deciding City of Hope's breach of contract claim. 30 The 
Court disposed of this contention by stating that credibility determinations 
were a role for the jury, which also had the task of interpreting the 
contractY 
Genentech further contended that a comment made to the jury to 
decide the breach of contract before resolving the breach of fiduciary duty 
was improperY However, the Court found this to be appropriate since the 
verdict forms instructed the jury as such. 33 
Lastly, Genentech contended that a jury instruction stating that 
fiduciary duties include action in the "utmost good faith and making full 
and fair disclosure of facts which materially affect City of Hope's rights 
and interests under the 197 6 agreement. "34 The jury was also instructed 
that it was to decide City of Hope's breach of contract claim separately 
from the breach of fiduciary duty. 35 These instructions, the Court reasoned, 
adequately distinguished the two claims and that it is presumed that the 
jury followed the instructions. 36 
The court also failed to see any impropriety on the part of City of 
Hope's counsel's "witness credibility" and "big picture" arguments in 
regards to determining the meaning of several contract provisions, stating 
that these were within the realm of the jury's functions. 37 The court also 
dismissed Genentech's challenge that City of Hope's counsel incorrectly 
informed the jury the order by which to decide key issues of the case.38 
Holding 
The Court held that (1) no fiduciary relationship arose from the 
contract between Genentech and City of Hope;39 and (2) the jury was not 
prejudiced in its decision regarding Genentech's breach of contract claim 
due to the concurrent admission of evidence relating to the City of Hope's 
breach of fiduciary duty claim. 40 
30 /d. at 155-56. 
31 /d. at 156. 
32 /d. 
33 /d. 
34 /d. (internal quotations omitted). 
35 /d. 
36 /d. 
37 !d. at 155-56. 
38 /d. at 156. 
39 /d. at 146, 158. 
40 !d. 
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Legal Significance 
As a result of this decision, the court modified the definition of 
fiduciary obligations in that one is not formed when a scientific discovery 
is, in exchange for royalties, entrusted to be developed, marketed, and 
exploited. The court also refrained from stifling commercial arrangements 
such as this by refusing to place a fiduciary duty on City of Hope. 
